���ϸ�����

News from ���ϸ����� Langone Health

Surmounting Obstacles To Get Black And Brown New Yorkers Listed For Organ Transplants. (Amsterdam (NY) News)

�ճ�� (9/11) The complex organ transplant process in the US, particularly for kidney and liver transplants, is hindered by inconsistent guidelines and communication issues between dialysis clinics and transplant centers, with ���ϸ����� Langone Health’s Kidney Transplant Program addressing these challenges by emphasizing timely evaluations and education for patients and physicians; Nicole M. Ali, MD, clinical associate professor, Department of Medicine, Division of Nephrology, ���ϸ����� Langone Transplant Institute said, “The messaging out there for New Yorkers is that there’s this perception that the waiting time for a kidney transplant in New York is 6 to 8 years ... Our median time to transplant at ���ϸ����� Langone  is 9.1 months.” 

Study Finds Toxic Contamination Still Present At Ringwood Mines Superfund Site. (New Jersey Herald)

 (9/11) Despite the Environmental Protection Agency’s previous assessments, new research by ���ϸ����� Langone Health, funded by the National Institutes of Health, indicates ongoing toxic contamination at the Ringwood Mines Superfund Site, prompting calls for further federal testing and cleanup efforts, with findings to be released publicly at a Sept. 16 event, featuring speakers Chief Vincent Mann and Judith Zelikoff, PhD, professor, Department of Medicine.

Also reporting are (9/11) and (9/11). 

There’s A Parenting Lesson Behind The ‘Phillies Karen’ Drama. (Yahoo! News (MYS)

 (9/11) Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, emphasized the importance of staying calm in confrontations, citing the viral incident where a father chose to de-escalate a situation at a Phillies game as a teaching moment for demonstrating rational behavior to children, saying, “When people are activated, they can be unpredictable,” adding, “It’s important to understand how to slow it down.” 

William Huang, MD, Highlights Data On Mitomycin For Intravesical Solution. (Urology Times)

(9/11) William C. Huang, MD, vice chair, clinical affairs, professor, Departments of Urology and Radiology, chief, urology service, Perlmutter Cancer Center, discussed the efficacy of mitomycin for intravesical solution in treating low-grade, intermediate-risk non–muscle invasive bladder cancer, based on data from the OPTIMA II and ENVISION trials, with the latter leading to FDA approval in June 2025. 

Commentary: Selling A Physician Practice: Ethical Obligations. (Medscape)

 (9/11)* Art Caplan, the Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics, highlights ethical concerns surrounding the sale of medical practices to private equity firms, emphasizing the need for transparency with patients regarding potential changes in care continuity and record handling.